Where does Anteris Technologies Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Anteris Technologies Corporation ranks #22,186 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Anteris Technologies Corporation hold?

Anteris Technologies Corporation holds 12 US utility patents granted between 2021 and 2025, spanning 5 technology areas.

What is Anteris Technologies Corporation's Innovation Score?

Anteris Technologies Corporation has an Innovation Score of 48.5 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Anteris Technologies Corporation's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Anteris Technologies Corporation.

What does claim depth mean for Anteris Technologies Corporation's patents?

Anteris Technologies Corporation's patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Anteris Technologies Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Anteris Technologies Corporation

Q: What technology areas does Anteris Technologies Corporation focus on?

Anteris Technologies Corporation's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 9 patents, ranking #711 of 3,082 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Anteris ranks #22,186 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.

#22,186
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.5/100): 19.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22186 · US Corporation #22,186 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 12 grants
MID-PACK #22,186/49,997
PHOTO-FINISH Ample
CPC-NARROW A61F · 5 areas
INNOV-PAR 48.5/100
CLAIMS-RICH 19.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Ample, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Anteris’s 48.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (18%) Velocity 20.0 pts (41%) Breadth 7.9 pts (16%) Claim depth 11.7 pts (24%)

Qualcomm Incorporated · highest

85
Anteris · this assignee

49
Beken · near

49
Belron International · near

49
Nidec PSA Emotors · near

49
Velcro Bvba · near

49
3D Lighting… · lowest

7

What this shows Anteris's Innovation Score is 48.5/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Anteris?

Each dot is one of Anteris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Anteris’s own 19.6 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Anteris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Anteris's grants concentrate

Anteris Technologies Corporation is a focused PatentsView assignee: 5 CPC subclasses with 75% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2021. By volume, Anteris sits between Ample, Inc. and Apexigen, Inc..

Anteris's three-year grant acceleration

Anteris Technologies Corporation shows 9 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ample

12
Analogix Semicond…

12
And B

12
Andritz Technolog…

12
Antheia

12
Antique Books

12
Anvis Deutschland

12
Apexigen

12
Anteris ◀

12

What this shows Anteris holds 12 patents at rank #22,214, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Anteris

By rank, the assignees closest to #22,214 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Anteris's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Anteris, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Anteris ranks #711 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Nidec PSA Emotors 49 Belron International Limited 49 Velcro Bvba 49 Beken Corporation 49

Anteris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Anteris Technologies Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	8.3%
2023	5	41.7%
2024	4	33.3%
2025partial year	2	16.7%

Which technologies does Anteris Technologies Corporation patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 9

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

A61B - DIAGNOSIS; SURGERY; Identification 2

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Anteris Technologies Corporation's patent record in context - here's where to go next.

Anteris Technologies Corporation's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 75% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #22,186 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Anteris Technologies Corporation against Ample, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.